GlassScriptPhysician profile
Kenneth Robert Bauer
NPI 1306937164
$665.33
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.62 · 2020: $161 · 2021: $283 · 2022: $106 · 2023: $18.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $262.61 | 2019-2022 | |
| Mannkind Corporation | $92.25 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $47.28 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.74 | 2020-2022 | |
| Bausch Health US, LLC | $29.78 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $29.25 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $25.60 | 2021 | |
| Dexcom, INC. | $20.06 | 2021 | |
| Boston Scientific Corporation | $18.50 | 2023 | |
| Xeris Pharmaceuticals, INC. | $17.11 | 2020 | |
| Tris Pharma INC | $16.68 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.53 | 2022 | |
| Currax Pharmaceuticals LLC | $14.99 | 2021 | |
| Avion Pharmaceuticals | $14.51 | 2019 | |
| Acella Pharmaceuticals, LLC | $13.43 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $13.01 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.